Evidence map›Paper›PMID 25880678›Full record

ArticleInfection control and hospital epidemiology2015

Risk factors for infection with Escherichia coli in nursing home residents colonized with fluoroquinolone-resistant E. coli.

Sara Manning, Ebbing Lautenbach, Pam Tolomeo, Jennifer H Han

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sara Manning1Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.
Ebbing Lautenbach2Division of Infectious Diseases,Department of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.
Pam Tolomeo3Center for Clinical Epidemiology and Biostatistics,University of Pennsylvania,Philadelphia,Pennsylvania.
Jennifer H Han2Division of Infectious Diseases,Department of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.
University of Pennsylvania · US

Funding

Quinolone resistant E coli in long term care facilitiesR01AG023792 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2005 to 2009
$2.8M
Mentoring and patient-oriented research in antimicrobial resistanceK24AI080942 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2009 to 2013
$853k
Carbapenem-Resistant Klebsiella Pneumoniae in Long-Term Acute Care HospitalsK01AI103028 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HAN, JENNIFER · 2013 to 2017
$669k
ACL HHS U54CK000163NCEZID CDC HHS U54 CK000163NCEZID CDC HHS U54-CK000163NIAID NIH HHS K01 AI103028NIAID NIH HHS K01-AI103028NIAID NIH HHS K24 AI080942NIAID NIH HHS K24-AI080942NIA NIH HHS R01 AG023792NIA NIH HHS R01-AG023792
6 · The paper itself

Abstract

A case-control study to determine risk factors for clinical infection with Escherichia coli was conducted among nursing home residents colonized with fluoroquinolone-resistant E. coli. Among 94 subjects, 11 (12%) developed infections with E. coli. Risk factors included the presence of a urinary catheter or tracheostomy, diabetes mellitus, and trimethoprim-sulfamethoxazole exposure.

Indexed as

AgedAged, 80 and overAnti-Bacterial AgentsCase-Control StudiesCross InfectionDiabetes ComplicationsDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsFemaleFluoroquinolonesHumansMaleMiddle AgedNursing HomesRisk FactorsAnti-Bacterial AgentsFluoroquinolonesTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID25880678
PMCPMC4402708
OpenAlexW2111976303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.